Tumor-infiltrating lymphocytes as a feasible adjuvant immunotherapy for osteosarcoma with a poor response to neoadjuvant chemotherapy

被引：17
|
作者：
Shi, Jing [1 ]
Li, Ming [1 ]
Yang, Rongzhi [1 ]
机构：
[1] Zhengzhou Univ, Dept Orthoped Surg, Luoyang Cent Hosp, Luoyang 471009, Peoples R China
来源：
IMMUNOTHERAPY | 2020年 / 12卷 / 09期
关键词：
adjuvant chemotherapy; adverse effects; immunotherapy; osteosarcoma; PD1; phenotype; poor response; prognostic factor; retrospective; TILs; SOUTHWEST-ONCOLOGY-GROUP; HIGH-GRADE OSTEOSARCOMA; METASTATIC MELANOMA; T-CELLS; NONMETASTATIC OSTEOSARCOMA; PROGNOSTIC-FACTORS; EWINGS-SARCOMA; OSTEO-SARCOMA; PHASE-II; CANCER;
D O I：
10.2217/imt-2020-0107
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Aim: To investigate the efficacy of adjuvant chemotherapy plus tumor-infiltrating lymphocytes (TILs) therapy in osteosarcoma patients with a poor response to neoadjuvant chemotherapy. Materials & methods: 40 patients received adjuvant chemotherapy (Group 1) and 40 patients received adjuvant chemotherapy plus TILs therapy (Group 2). Disease-free survival (DFS) and overall survival (OS) were analyzed by Kaplan-Meier analysis. Results: The median DFS (mDFS; 65.3 months) and median OS (mOS; 95.8 months) in Group 2 were significantly prolonged compared with those in Group 1 (55.5 months for mDFS and 80.4 months for mOS). Univariate and multivariate analyses indicated that a greater number of TILs transfused was an independent prognostic factor for both mDFS and mOS. Conclusion: Adjuvant chemotherapy plus TILs therapy may prolong survival of patients with a poor response to neoadjuvant chemotherapy.
引用
收藏
页码：641 / 652
页数：12
相关论文
共 50 条
  • [21] Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy
    Lo, Charlotte S.
    Sanii, Sanaz
    Kroeger, David R.
    Milne, Katy
    Talhouk, Aline
    Chiu, Derek S.
    Rahimi, Kurosh
    Shaw, Patricia A.
    Clarke, Blaise A.
    Nelson, Brad H.
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (04) : 925 - 934
  • [22] Change of Tumor-Infiltrating Lymphocytes after Neoadjuvant Chemotherapy & Their Clinical Significance in Breast Cancer
    Lee, Mieson
    Kim, Bo-Im
    Bang, Won Seon
    Gong, Gyungyub
    Lee, Hee Jin
    [J]. MOLECULAR THERAPY, 2019, 27 (04) : 389 - 389
  • [23] Tumor Infiltrating Lymphocytes and Response To Neoadjuvant Chemotherapy in Invasive Breast Cancer
    Fineberg, Susan
    McLemore, Lauren
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 45A - 45A
  • [24] PD-L1 Expression Correlates with Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy in Breast Cancer
    Wimberly, Hallie
    Brown, Jason R.
    Schalper, Kurt
    Haack, Herbert
    Silver, Matthew R.
    Nixon, Christian
    Bossuyt, Veerle
    Pusztai, Lajos
    Lannin, Donald R.
    Rimm, David L.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2015, 3 (04) : 326 - 332
  • [25] Tumor Infiltrating Lymphocytes and Response To Neoadjuvant Chemotherapy in Invasive Breast Cancer
    Fineberg, Susan
    McLemore, Lauren
    [J]. MODERN PATHOLOGY, 2015, 28 : 45A - 45A
  • [26] CANCER-IMMUNOTHERAPY USING TUMOR-INFILTRATING LYMPHOCYTES
    FIGLIN, RA
    [J]. SEMINARS IN HEMATOLOGY, 1992, 29 (02) : 33 - 35
  • [27] TUMOR-INFILTRATING LYMPHOCYTES
    KRADIN, RL
    BHAN, AK
    [J]. LABORATORY INVESTIGATION, 1993, 69 (06) : 635 - 638
  • [28] THE EFFICACY OF INTENSIFIED ADJUVANT CHEMOTHERAPY IN OSTEOSARCOMA PATIENTS WITH METASTATIC DISEASE OR POOR RESPONSE TO NEOADJUVANT CHEMOTHERAPY
    Kim, Hyery
    Koh, Kyung-Nam
    Yoo, Jae Won
    Kang, Sung Han
    Lee, Jong-Seok
    Choi, Se-Hoon
    Kim, Dong Kwan
    Im, Ho Joon
    Seo, Jong Jin
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65
  • [29] Effects of tumor-infiltrating lymphocytes on nonresponse rate of neoadjuvant chemotherapy in patients with invasive breast cancer
    Qian, Xiao-Long
    Xia, Xiao-Qing
    Li, Ya-Qing
    Jia, Yu-Mian
    Sun, Yuan-Yuan
    Song, Yuan-Ming
    Xue, Hui-Qin
    Hao, Yan-Fei
    Wang, Jin
    Wang, Xiao-Zi
    Liu, Chen-Ying
    Zhang, Xin-Min
    Zhang, Li-Na
    Guo, Xiao-Jing
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [30] Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy
    Nejati, Reza
    Goldstein, Jennifer B.
    Halperin, Daniel M.
    Wang, Hua
    Hejazi, Nazila
    Rashid, Asif
    Katz, Matthew H.
    Lee, Jeffrey E.
    Fleming, Jason B.
    Rodriguez-Canales, Jaime
    Blando, Jorge
    Wistuba, Ignacio I.
    Maitra, Anirban
    Wolff, Robert A.
    Varadhachary, Gauri R.
    Wang, Huamin
    [J]. PANCREAS, 2017, 46 (09) : 1180 - 1187
12345